Dr. Daniel Harry Jacobs, MD

Dr. Jacobs practices at Neurological Services of Orlando PA in Orlando, Florida.

Dr. Jacobs' NPI, 1356323166, was assigned on November 17, 2005. Dr. Jacobs graduated from University of Kansas School of Medicine - Kansas City in 1987. Dr. Jacobs holds Florida license ME0063521.

Dr. Jacobs' primary practice is Neurological Services of Orlando PA, at 3849 Oakwater Cir, Orlando, FL 32806 in Orange County. The practice phone is (407) 240-1762.

Dr. Jacobs' primary practice is Neurological Services of Orlando PA in Orlando, Florida. Dr. Jacobs is also affiliated with AdventHealth Orlando. The medical group on file is Orlando Health Medical Group. Dmand AI also links Dr. Jacobs to 2 more hospitals, 5 group practices and clinics, 4 medical groups and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Jacobs practices, 9 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Jacobs' primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Jacobs is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Jacobs' licenses on file in 2 states: Florida and Massachusetts.

Dmand AI lists acute mini-stroke (TIA), alzheimer's disease, carpal tunnel syndrome, cerebrovascular disease, encephalopathy, epilepsy, essential tremor and fibromyalgia and chronic pain among the conditions Dr. Jacobs treats.

CMS data shows 19,275 Medicare services from Dr. Jacobs across 17 procedure codes in 2024, for 422 Medicare patients. Medicare paid $805,195 for them. Every service was in an office.

CMS counts 422 Medicare patients who saw Dr. Jacobs in 2024. The largest group is 75 to 84, with 181 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Jacobs' median patient age at 65, with 63% women.

In 2024, Dr. Jacobs wrote 2,666 Medicare Part D claims for 419 patients. 88% of them were for generic drugs. CMS names the drug for 2,184 of them, across 55 drugs with 11 or more claims each, at $1,217,985 in total drug cost. In 2023, CMS named 2,244 claims across 67 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Jacobs for performance year 2024, reported individually. Dr. Jacobs accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Jacobs as offering telehealth.

Dmand AI links 26 papers to Dr. Jacobs, published from 2010 to 2023. 2020 was the busiest year, with 2. The most frequent topics are Brain, Neuropsychological Tests and Apraxias. Dr. Jacobs has published most often in Neurology. Dr. Jacobs' most frequent co-authors are Michael Benatar, MD, James L. Bicksel, MD and Jean E. Cibula, MD.

CMS Open Payments shows 2,098 general payments to Dr. Jacobs from 84 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 50% of the total. Sanofi and Genzyme US Companies paid the most, $23,986.

Dmand AI lists 1 award for Dr. Jacobs, most recently CMS Stage 1 EHR in 2013.

Dr. Jacobs graduated from University of Kansas School of Medicine - Kansas City in 1987.

Dr. Jacobs is in network with 14 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.